Among the wave of guidance documents issued by the U.S. Food and Drug Administration (“FDA” or the “Agency”) in the first week of 2025 were ...

Obesity-drug maker Metsera Inc.'s stock jumped 47% on Friday as the biggest gainer among three initial public offerings bucking a swoon in the equity market to rise in their stock-market debuts Friday ...

ColdVentures enters exclusive distribution partnership with Medco Sports Medicine: Los Angeles Monday, January 27, 2025, 16:00 Hrs [IST] ColdVentures, a leading medical device com ...

The FDA has approved a new indication for semaglutide to lower the risk for worsening kidney disease, kidney failure and cardiovascular death among adults with type 2 diabetes and chronic kidney ...

BUT HE SA Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes ... indicated drug in its class, with the largest set of specific medical conditions that ...

For this study, researchers focused on the SGLT-2 drug dapagliflozin, and how it worked in combination with a calorie-restricted diet. “SGLT-2 inhibits are a class of medications that inhibit ...

Several ASX-listed companies are undertaking phase III clinical trials, the critical final stage before potential regulatory ...

Los Angeles, CA, January 27, 2025 (GLOBE NEWSWIRE)- KRONOS ADVANCED TECHNOLOGIES, INC. (OTC MARKETS: KNOS) ("KNOS" or the "Company"), a leader in innovation-driven ...

While the brand originally initiated the recall in December, the FDA just recently classified the recall as a Class II, meaning “a situation in which use of, or exposure to, a violative product ...

I’m An ER Doctor. When I Became A Patient For The First Time, I Was Shocked By What I Experienced.

The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...